In appropriate patients, medically supervised GLP-1 therapy has been associated with: Sustained weight reduction over time Improvements in A1C and overall blood sugar in people with type 2 diabetes Reduced waist circumference and visceral fat Better blood pressure, cholesterol, and other metabolic markers In some studies with Wegovy, a reduced risk of certain serious cardiovascular events in adults with obesity and existing heart disease At NuIQ, the goal of our GLP-1 semaglutide program is not just fast weight lossits sustainable weight management, better energy, and long-term metabolic health, all under the guidance of licensed medical professionals
Outcome Thresholds Clinically meaningful thresholds were established based on HF research as follows: MACE: a relative risk reduction of 10% in cardiovascular death, non-fatal MI, and non-fatal stroke was considered clinically meaningful
The plaintiffs argue that these controls are overly restrictive and prevent patients from getting needed care
Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M
